Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter LaPan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|July 27, 2016
CATO: The Clone Alignment ToolPeter V Henstock, Peter LaPan
Assay and Drug Development Technologies|November 28, 2008
Quantitative optimization of reverse transfection conditions for 384-well siRNA library screeningPeter LaPan, Jing Zhang, Jing Pan, et al.
BMC Bioinformatics|September 18, 2007
Impact of image segmentation on high-content screening data quality for SK-BR-3 cellsAndrew A Hill, Peter LaPan, Yizheng Li, et al.
Drug Discovery Today|September 26, 2006
High-content screening moves to the front of the lineSteven A Haney, Peter LaPan, Jing Pan, et al.
BMC Cell Biology|August 5, 2008
Single cell cytometry of protein function in RNAi treated cells and in native populationsPeter LaPan, Jing Zhang, Jing Pan, et al.
Plos One|September 24, 2009
Image-based assessment of growth and signaling changes in cancer cells mediated by direct cell-cell contactPeter Lapan, Jing Zhang, Andrew Hill, et al.
BMC Pulmonary Medicine|August 4, 2010
Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputumPeter LaPan, Jeff Brady, Christal Grierson, et al.
Journal of Biomolecular Screening|April 18, 2013
A kinome-wide siRNA screen identifies multiple roles for protein kinases in hypoxic stress adaptation, including roles for IRAK4 and GAK in protection against apoptosis in VHL-/- renal carcinoma cells, despite activation of the NF-κB pathwayJing Pan, Jing Zhang, Andrew Hill, et al.
Antibodies (Basel, Switzerland)|September 28, 2019
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|July 27, 2016
CATO: The Clone Alignment ToolPeter V Henstock, Peter LaPan
Assay and Drug Development Technologies|November 28, 2008
Quantitative optimization of reverse transfection conditions for 384-well siRNA library screeningPeter LaPan, Jing Zhang, Jing Pan, et al.
BMC Bioinformatics|September 18, 2007
Impact of image segmentation on high-content screening data quality for SK-BR-3 cellsAndrew A Hill, Peter LaPan, Yizheng Li, et al.
Drug Discovery Today|September 26, 2006
High-content screening moves to the front of the lineSteven A Haney, Peter LaPan, Jing Pan, et al.
BMC Cell Biology|August 5, 2008
Single cell cytometry of protein function in RNAi treated cells and in native populationsPeter LaPan, Jing Zhang, Jing Pan, et al.
Plos One|September 24, 2009
Image-based assessment of growth and signaling changes in cancer cells mediated by direct cell-cell contactPeter Lapan, Jing Zhang, Andrew Hill, et al.
BMC Pulmonary Medicine|August 4, 2010
Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputumPeter LaPan, Jeff Brady, Christal Grierson, et al.
Journal of Biomolecular Screening|April 18, 2013
A kinome-wide siRNA screen identifies multiple roles for protein kinases in hypoxic stress adaptation, including roles for IRAK4 and GAK in protection against apoptosis in VHL-/- renal carcinoma cells, despite activation of the NF-κB pathwayJing Pan, Jing Zhang, Andrew Hill, et al.
Antibodies (Basel, Switzerland)|September 28, 2019
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.
Pageof 1